Clinical trial
Prospective Observational Study Evaluating the Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Bronchiectasis, Lymphopenia and/or Immunoglobulin E Elevation in Pulmonology Clinics
NCT05300347 is registered in ClinicalTrials.gov with TRPHARM as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study Evaluating the Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Bronchiectasis, Lymphopenia and/or Immunoglobulin E Elevation in Pulmonology Clinics
- Lead sponsor
- TRPHARM
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 17, 2021
- Completion date
- June 17, 2023
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenosine deaminase deficiency, bronchiectasis, pulmonary disease